168 related articles for article (PubMed ID: 33131746)
1. Low-dose cannabinoid receptor 2 agonist induces microglial activation in a cancer pain-morphine tolerance rat model.
Ma C; Zhang M; Liu L; Zhang P; Liu D; Zheng X; Zhong X; Wang G
Life Sci; 2021 Jan; 264():118635. PubMed ID: 33131746
[TBL] [Abstract][Full Text] [Related]
2. Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats.
Zhang M; Wang K; Ma M; Tian S; Wei N; Wang G
Anesth Analg; 2016 Apr; 122(4):1031-7. PubMed ID: 26720619
[TBL] [Abstract][Full Text] [Related]
3. Effects of coadministration of low dose cannabinoid type 2 receptor agonist and morphine on vanilloid receptor 1 expression in a rat model of cancer pain.
Zhang M; Chi M; Zou H; Tian S; Zhang Z; Wang G
Mol Med Rep; 2017 Nov; 16(5):7025-7031. PubMed ID: 28901432
[TBL] [Abstract][Full Text] [Related]
4. Effects of Cannabinoid Type 2 Receptor Agonist AM1241 on Morphine-Induced Antinociception, Acute and Chronic Tolerance, and Dependence in Mice.
Zhang M; Dong L; Zou H; Li J; Li Q; Wang G; Li H
J Pain; 2018 Oct; 19(10):1113-1129. PubMed ID: 29729431
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4-mediated nuclear factor-κB activation in spinal cord contributes to chronic morphine-induced analgesic tolerance and hyperalgesia in rats.
Bai L; Zhai C; Han K; Li Z; Qian J; Jing Y; Zhang W; Xu JT
Neurosci Bull; 2014 Dec; 30(6):936-948. PubMed ID: 25446875
[TBL] [Abstract][Full Text] [Related]
6. Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.
Curto-Reyes V; Llames S; Hidalgo A; Menéndez L; Baamonde A
Br J Pharmacol; 2010 Jun; 160(3):561-73. PubMed ID: 20233215
[TBL] [Abstract][Full Text] [Related]
7. p38 and interleukin-1 beta pathway via toll-like receptor 4 contributed to the skin and muscle incision and retraction-induced allodynia.
Chen H; Jiang YS; Sun Y; Xiong YC
J Surg Res; 2015 Aug; 197(2):339-47. PubMed ID: 25979559
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid Receptor Type 2 Agonist Reduces Morphine Tolerance via Mitogen Activated Protein Kinase Phosphatase Induction and Mitogen Activated Protein Kinase Dephosphorylation.
Kong Q; Tian S; Ma C; Wang G; Zhang M
Neuroscience; 2022 Jan; 480():56-64. PubMed ID: 34774714
[TBL] [Abstract][Full Text] [Related]
9. Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway.
Chen Y; Geis C; Sommer C
J Neurosci; 2008 May; 28(22):5836-45. PubMed ID: 18509045
[TBL] [Abstract][Full Text] [Related]
10. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
[TBL] [Abstract][Full Text] [Related]
11. Promoted inhibition of TLR4/miR-155/ NF
Ali AM; El-Tawil OS; Al-Mokaddem AK; Abd El-Rahman SS
Chem Biol Interact; 2021 Feb; 336():109398. PubMed ID: 33503444
[TBL] [Abstract][Full Text] [Related]
12. Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors.
Su TF; Zhao YQ; Zhang LH; Peng M; Wu CH; Pei L; Tian B; Zhang J; Shi J; Pan HL; Li M
Eur J Pain; 2012 May; 16(5):624-35. PubMed ID: 22337285
[TBL] [Abstract][Full Text] [Related]
13. Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats.
Qian J; Zhu Y; Bai L; Gao Y; Jiang M; Xing F; Zhang J; Zhao W; Gu H; Mi Y; Tao YX; Xu JT
Neurotherapeutics; 2020 Apr; 17(2):722-742. PubMed ID: 31879851
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.
Quartilho A; Mata HP; Ibrahim MM; Vanderah TW; Porreca F; Makriyannis A; Malan TP
Anesthesiology; 2003 Oct; 99(4):955-60. PubMed ID: 14508331
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling.
Han Y; Jiang C; Tang J; Wang C; Wu P; Zhang G; Liu W; Jamangulova N; Wu X; Song X
Eur J Pain; 2014 Nov; 18(10):1458-70. PubMed ID: 24756886
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor 2‑selective agonist JWH015 attenuates bone cancer pain through the amelioration of impaired autophagy flux induced by inflammatory mediators in the spinal cord.
Mao Y; Huang Y; Zhang Y; Wang C; Wu H; Tian X; Liu Y; Hou B; Liang Y; Rong H; Gu X; Ma Z
Mol Med Rep; 2019 Dec; 20(6):5100-5110. PubMed ID: 31661120
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Diet-Induced Obese Rats with CB
O'Keefe L; Vu T; Simcocks AC; Jenkin KA; Mathai ML; McAinch AJ; Hutchinson DS; Hryciw DH
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108770
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid WIN-55,212-2 mesylate inhibits tumor necrosis factor-α-induced expression of nitric oxide synthase in dorsal root ganglion neurons.
Tan R; Cao L
Int J Mol Med; 2018 Aug; 42(2):919-925. PubMed ID: 29786105
[TBL] [Abstract][Full Text] [Related]
19. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Makriyannis A; Hohmann AG
Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
[TBL] [Abstract][Full Text] [Related]
20. Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats.
Hsieh GC; Pai M; Chandran P; Hooker BA; Zhu CZ; Salyers AK; Wensink EJ; Zhan C; Carroll WA; Dart MJ; Yao BB; Honore P; Meyer MD
Br J Pharmacol; 2011 Jan; 162(2):428-40. PubMed ID: 20880025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
